Therapeutic archive
ISSN 0040-3660 (Print)
ISSN 2309-5342 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Home
>
Search
>
Author Details
Author Details
Князев, О В
Issue
Section
Title
File
Vol 84, No 8 (2012)
Editorial
Optimization of cell therapy in patients with inflammatory bowel diseases
Vol 84, No 12 (2012)
Editorial
Complete elimination of cytomegalovirus without antiviral therapy after systemic mesenchymal stromal cell transplantation in a patient with ulcerative colitis (a clinical case)
Vol 85, No 2 (2013)
Editorial
New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases
Vol 85, No 12 (2013)
Editorial
Immune response to biological therapy for inflammatory bowel diseases
Vol 86, No 2 (2014)
Editorial
Value of adhesion molecules for evaluating the efficiency of therapy for ulcerative colitis and Crohn's disease
Vol 86, No 2 (2014)
Editorial
Combination biological therapy for fistular Crohn's disease: Clinical demonstration
Vol 87, No 2 (2015)
Editorial
Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: Results of a 5-year follow-up
Vol 88, No 2 (2016)
Editorial
Use of mesenchymal stem cells in the combination therapy of ulcerative colitis
(Rus)
Vol 88, No 8 (2016)
Editorial
Long-term infliximab therapy for ulcerative colitis in real clinical practice
(Rus)
Vol 89, No 2 (2017)
Editorial
Efficacy of adalimumab for Crohn’s disease in real clinical practice
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP